DIECI, MARIA VITTORIA

DIECI, MARIA VITTORIA  

Dipartimento di Scienze Chirurgiche Oncologiche e Gastroenterologiche - DiSCOG  

Mostra records
Risultati 1 - 20 di 198 (tempo di esecuzione: 0.037 secondi).
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
A 3D morphogenetic blueprint for metastatic outgrowth in breast cancer 2026 Caire, RobinZanconato, FrancescaPanciera, TitoAudoux, EstelleContessotto, PaoloRomano, OrianaSuli, AmbelaBattilana, GiusyMarchionni, MatteoDieci, Maria VittoriaGriguolo, GaiaFassan, MatteoGuzzardo, VincenzaDei Tos, Angelo PaoloBicciato, SilvioGuarneri, ValentinaCordenonsi, Michelangelo + CELL - -
Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2 2026 Dieci, Maria VittoriaMenichetti, AliceGriguolo, GaiaGuarneri, ValentinaMariani, Luigi + BREAST - -
Proactive Brain Screening Using Contrast-Enhanced Brain CT Scans in HER2+ Metastatic Breast Cancer 2026 Gaia GriguoloMichele BottossoGiorgio BonomiFederica MigliettaMaria Vittoria DieciValentina Guarneri + CLINICAL CANCER RESEARCH - -
A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients 2025 Dieci, M. V.Guarneri, V. + ANNALS OF ONCOLOGY - -
Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapy 2025 Miglietta, FedericaDieci, Maria VittoriaGuarneri, Valentina + NPJ BREAST CANCER - -
Artificial intelligence and tumour-infiltrating lymphocytes in breast cancer: bridging innovation and feasibility towards clinical utility 2025 Miglietta, FedericaDieci, Maria Vittoria THE LANCET. DIGITAL HEALTH - -
Association between risk-reducing surgeries and survival in young BRCA carriers with breast cancer: an international cohort study 2025 Maria Vittoria Dieci + THE LANCET ONCOLOGY - -
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications 2025 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaBicciato, SilvioTosi, AnnaSchiavi, FrancescaDieci, Maria VittoriaGuarneri, Valentina + NPJ BREAST CANCER - -
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status 2025 Dieci, Maria Vittoria + JOURNAL OF CLINICAL ONCOLOGY - -
Comprehensive Diagnostic and Therapeutic Approaches for Estrogen Receptor-Low Breast Cancer: A Multidisciplinary Perspective From Oncologists and Pathologists 2025 Dieci, Maria VittoriaRizzo, Antonio + JCO ONCOLOGY PRACTICE - -
Current controversies in the use of Oncotype DX in early breast cancer 2025 Dieci, Maria Vittoria + CANCER TREATMENT REVIEWS - -
Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept study 2025 Miglietta, F.Collesei, A.Griguolo, G.Massa, D.Fassan, M.Dei Tos, A. P.Dieci, M. V.Guarneri, V. + ESMO OPEN - -
Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis 2025 Dieci, Maria Vittoria + ECLINICALMEDICINE - -
Exceptional responses to systemic treatment in metastatic breast cancer: clinical features and long-term outcomes 2025 Griguolo, GaiaBottosso, MicheleMiglietta, FedericaBonomi, GiorgioMassa, DavideDieci, Maria VittoriaGuarneri, Valentina + EUROPEAN JOURNAL OF CANCER - -
Gene expression profiling in a retrospective real-world cohort of breast cancer brain metastases and paired primary tumors identifies biological changes with potential therapeutic implications 2025 Griguolo, GDieci, M VBottosso, MMiglietta, FZanconato, FSchiavi, FFassan, MDei Tos, A PPiccolo, SGuarneri, V + ESMO OPEN - -
HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis 2025 Valentina GuarneriMaria Vittoria DieciGaia Griguolo + THE LANCET ONCOLOGY - -
Impact of germline BRCA1/2 status on outcomes for patients with HR+/HER2- metastatic breast cancer treated with CDK4/6 inhibitors: a systematic review and meta-analysis 2025 Bottosso, MicheleMiglietta, FedericaDieci, Maria VittoriaGriguolo, GaiaGuarneri, Valentina + THE BREAST - -
Incidence of non-colorectal/endometrial malignancies in individuals with Lynch syndrome: a retrospective cohort study 2025 Negro, SilviaSchiavi, FrancescaScarpa, MarcoRossi, SilviaFassan, MatteoAgostini, MarcoSpolverato, GayaD'Angelo, EdoardoGuarneri, ValentinaDieci, Maria VittoriaIafrate, MassimoUrso, Emanuele D L + ECLINICALMEDICINE - -
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial 2025 Dieci, M VMiglietta, FGuarneri, V + ESMO OPEN - -
Omitting anthracyclines for the adjuvant treatment of patients with triple-negative breast cancer: A non-inferiority meta-analysis 2025 Griguolo, GaiaDieci, Maria VittoriaGuarneri, Valentina + THE BREAST - -